1. Introduction {#j_med-2018-0079_s_001}
===============

Incisional hernia mesh repair is a common routine operation worldwide. One of the most commonly occurring complications is postoperative seroma, others such as hematoma or subcutaneous abscess are less common \[[@j_med-2018-0079_ref_001]\]. Formation of postoperative seroma varies widely from 3 to 100% with a peak presentation at the 7^th^ postoperative day. Moreover, guidelines did not distinguish between clinically significant and asymptomatic seromas \[[@j_med-2018-0079_ref_002]\]. Recent prospective study revealed 100% incidence of seroma after mesh repair, following with all and complete spontaneous resolution within 90 days after initial surgery \[[@j_med-2018-0079_ref_003]\]. Meanwhile, formation of chronic and greater in size subcutaneous cysts or pseudocysts are exceedingly rare after these operations. Only 35 cases have been presented worldwide in single cases or case series from the 1993 up to date ([Table 1](#j_med-2018-0079_tab_001){ref-type="table"}). Incidence of small case series varies from 0.45 % to 0.8 % suggesting its rare prevalence or lack of reports in scientific literature \[[@j_med-2018-0079_ref_004]\].

###### 

Case reports of pseudocysts after hernia repair with mesh

  Year   First author                                    Case no   Age   M/F   Hernia type                   Size/volume (cm/ml)   Mesh      Treatment                   Onset time
  ------ ----------------------------------------------- --------- ----- ----- ----------------------------- --------------------- --------- --------------------------- ------------
  1993   Waldrep \[[@j_med-2018-0079_ref_001]\]          1         62    F     Incisional                    20 x 15               Marlex    Excision                    NM
                                                         2         78    F     Incisional                    13 x 7                Marlex    Excision                    12
  1998   Arya \[[@j_med-2018-0079_ref_005]\]             3         74    F     Incisional                    17 x 12               Prolene   Excision                    2
  2004   Ogunbiyi \[[@j_med-2018-0079_ref_006]\]         4         37    F     Incisional                    25 x 18               Prolene   Excision                    24
                                                         5         68    F     Spiegel                       NM                    Prolene   Excision                    12
                                                         6         66    F     Incisional                    NM                    Prolene   Excision                    4
                                                         7         46    F     Incisional                    NM                    Prolene   Excision                    3
                                                         8         83    M     Incisional                    NM                    Prolene   Excision                    3
  2006   Mayagoitia \[[@j_med-2018-0079_ref_019]\]       9         60    F     Incisional                    20 x 25               Prolene   Excision                    2
                                                         10        77    F     Incisional                    25 x 30               Prolene   Excision                    4
  2006   Mehrotra \[[@j_med-2018-0079_ref_013]\]         11        56    F     Incisional                    32 x 25               Prolene   Laparoscopic excision       1
  2007   Sahin-To´th \[[@j_med-2018-0079_ref_011]\]      12        31    F     Incisional                    NM                    Prolene   Excision                    4
                                                         13        44    M     Incisional                    NM                    Prolene   Excision                    8
                                                         14        57    F     Incisional                    NM                    Prolene   Excision                    25
                                                         15        78    F     Incisional                    NM                    Prolene   Excision                    15
                                                         16        70    M     Incisional                    NM                    Prolene   Excision                    5
  2008   Narayanan \[[@j_med-2018-0079_ref_014]\]        17        42    F     Incisional + abdominoplasty   2000 ml               Prolene   Excision                    6
  2008   Hoefkens \[[@j_med-2018-0079_ref_015]\]         18        79    F     Incisional                    20 x 24               Prolene   Excision                    NM
  2008   Omundsen \[[@j_med-2018-0079_ref_016]\]         19        49    F     Incisional                    4 x 3                 Prolene   Debridment                  4
  2011   Ielpo \[[@j_med-2018-0079_ref_004]\]            20        46    F     Incisional                    16 x 10               Prolene   Excision                    7
                                                         21        58    M     Incisional                    21 x 18               Prolene   Excision                    11
                                                         22        79    F     Incisional                    12 x 9                Prolene   Excision                    19
                                                         23        55    F     Incisional                    25 x 28               Prolene   Excision                    15
                                                         24        74    F     Incisional                    13 x 10               Prolene   Refused surgery             21
                                                         25        83    F     Incisional                    17 x 12               Prolene   Refused surgery             5
                                                         26        63    F     Incisional                    11 x 13               Prolene   Aspirations only            4
  2012   Ielpo \[[@j_med-2018-0079_ref_009]\]            27        63    M     Inguinal                      10 x 6                Prolene   Excision (partial)          5
                                                         28        61    M     Inguinal                      11 x 5                Prolene   Excision (partial)          7
  2013   Salgaonkar \[[@j_med-2018-0079_ref_007]\]       29        71    F     Incisional                    25 x 20               NM        Excision                    3
                                                         30        56    F     Incisional                    1300 ml               Prolene   Excision                    10
  2014   Saavedra-Perez \[[@j_med-2018-0079_ref_008]\]   31        79    F     Incisional                    31 x 19               PTFE\*    Excision                    NM
  2014   Mantelou \[[@j_med-2018-0079_ref_012]\]         32        78    F     Incisional                    18 x 13               Prolene   Excision                    NM
  2014   Vasilakis \[[@j_med-2018-0079_ref_017]\]        33        52    M     Incisional                    10 x 17               NM        Excision (partial)          NM
  2015   Narkhede \[[@j_med-2018-0079_ref_018]\]         34        36    F     Incisional                    24 x 15               Prolene   Excision                    18
  2016   van Loon \[[@j_med-2018-0079_ref_010]\]         35        63    M     Inguinal                      16                    NM        Laparoscopic fenestration   6
  2017   Current report                                  36        54    M     Incisional                    17 x 15               Prolene   Excision                    6

NM -- not mentioned, \*PTFE -- polytetrafluoroethylene

2. Case report {#j_med-2018-0079_s_002}
==============

We present the case of a 54-year-old obese (body mass index 33.7 kg/m^2^), diabetic male patient presenting with a large palpable mass in the anterior abdominal wall ([Figure 1](#j_med-2018-0079_fig_001){ref-type="fig"}). An anamnesis of the disease starts with a midline laparotomy incision which was performed due to descending colon tumour in August 2014. Final pathological diagnosis revealed well differentiated (G2) pT4bN0 mucinous adenocarcinoma without distant metastases. An adjuvant chemotherapy using FOLFOX4 regimen was admitted. There was no evidence of local recurrence or disease spread observed two years after primary operation. Nevertheless, an incisional hernia was confirmed during routine check-up. A patient underwent an onlay polypropylene mesh repair for an incisional hernia in September 2016. Later, the abdominal mass developed gradually over the several months before the presentation to the outpatient department of our hospital. All laboratory investigations were within normal parameters. A computed tomography (CT) scan of the abdomen was performed to establish the diagnosis and rule out tumour recurrence. CT indicated 170 x 153 x 217 mm well-defined cystic lesion (\~15 HU) with thickened partitions and flat contact with muscles of the anterior abdominal wall ([Figure 2](#j_med-2018-0079_fig_002){ref-type="fig"}). An aspiration of the 2500 ml dark coloured cystic content (serohemorrhagic fluid) was performed. Nevertheless, the decrease in volume was temporary and one month later cystic lesion was the same size like before aspiration. A multidisciplinary team decision was made and operative treatment was suggested to the patient. Extirpation of the cyst was accomplished and no defect in the abdominal wall was observed ([Figure 3](#j_med-2018-0079_fig_003){ref-type="fig"}, [4](#j_med-2018-0079_fig_004){ref-type="fig"}). Two drains were placed in residual place, which were removed on the 2^nd^ postoperative day. After removal of the excess of the skin, the subcutaneous layer and skin were sutured by individual stitches ([Figure 5](#j_med-2018-0079_fig_005){ref-type="fig"}). The removed specimen was sent for pathological evaluation ([Figure 6a, 6b](#j_med-2018-0079_fig_006){ref-type="fig"}), which revealed granulomatous inflammation in fibrotic wall of the pseudocyst. There was no growth of bacterial cultures in the fluid. The patient was discharged on the 7^th^ postoperative day. Ultrasonography two weeks after discharge again showed fluid collection. There were 6 aspirations every week starting with 400 ml serous fluid at the beginning and 60 ml at the end.

![Presentation of the abdomen before the operation](med-13-539-g001){#j_med-2018-0079_fig_001}

![Giant cystic lesion on the computed tomography scan](med-13-539-g002){#j_med-2018-0079_fig_002}

![Excision of the encapsulated seroma in progress](med-13-539-g003){#j_med-2018-0079_fig_003}

![Anterior abdominal wall after encapsulated seroma excision](med-13-539-g004){#j_med-2018-0079_fig_004}

![Anterior abdominal wall after wound closure](med-13-539-g005){#j_med-2018-0079_fig_005}

![Removed specimen](med-13-539-g006){#j_med-2018-0079_fig_006}

No hernia recurrence, seroma or other complication was observed one month after the last aspiration.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.

Informed consent: Informed consent has been obtained from the individual included in this study.

3. Discussion {#j_med-2018-0079_s_003}
=============

There are either no, or non-specific, symptoms in early stages of the disease. Usually, patients are admitted to hospital due to abdominal mass, which had increased in the course of a few months \[[@j_med-2018-0079_ref_001],[@j_med-2018-0079_ref_005],[@j_med-2018-0079_ref_006]\]. A medical history of previous incisional hernia repair using polypropylene mesh is presented the majority of these cases \[[@j_med-2018-0079_ref_004],[@j_med-2018-0079_ref_007],[@j_med-2018-0079_ref_008]\], less commonly after inguinal hernioplasty \[[@j_med-2018-0079_ref_009],[@j_med-2018-0079_ref_010]\]. A tense cystic palpable mass with fluctuation is presented during clinical examination. Additionally an ultrasonography reveals fluid cyst with thick external wall and internal septations with or without debris inside \[[@j_med-2018-0079_ref_004],[@j_med-2018-0079_ref_006],[@j_med-2018-0079_ref_011]\]. Abdominal CT confirms pseudocystic appearance and clarifies extraperitoneal location ruling out recurrent incarcerated incisional hernia from differential diagnosis \[[@j_med-2018-0079_ref_004],[@j_med-2018-0079_ref_007], [@j_med-2018-0079_ref_008], [@j_med-2018-0079_ref_009], [@j_med-2018-0079_ref_012]\]. While prevalence of giant pseudocyst is low, etiology also remains unclear. Other authors suggest manifestation of simple seroma or complication of postoperative hematoma. Formation of seroma is associated with disrupted lymphatic drainage due to intraoperative dissection of subcutaneous space. Meanwhile, postoperative hematomas sometimes tend to organize and clinically appear as gigantic pseudocyst \[[@j_med-2018-0079_ref_004],[@j_med-2018-0079_ref_005],[@j_med-2018-0079_ref_009]\]. Onlay technique was used in most cases as it reported. Thus, prosthetic mesh may support inflammatory process in postoperative course \[[@j_med-2018-0079_ref_012]\].

Worthy of mention is that onset time from initial hernioplasty to diagnosis of pseudocyst varies extremely, from

1 to 25 months. The diameter of the pseudocysts varies from 13 x 7 cm to 32 x 25 cm in reviewed cases, respectively. Predominantly giant pseudocysts occur in females (27) in comparison with males (9) ([Table 1](#j_med-2018-0079_tab_001){ref-type="table"}).

Conservative treatment was fruitless or even not considered due to thick wall, internal septations and dense content of the cyst in presented cases. Surgical treatment appears to be simple and effective for giant pseudocysts. No recurrence was reported during postoperative follow-up period in all cases.

4. Conclusion {#j_med-2018-0079_s_004}
=============

Surgical treatment of giant pseudocyst after incisional hernia mesh repair is safe and feasible despite its low prevalence.

**Disclosure statement**: No potential conflict of interest was reported by the authors.
